Literature DB >> 17382921

Matrix proteases, green tea, and St. John's wort: biomedical research catches up with folk medicine.

Isabella Dell'Aica1, Rosy Caniato, Susan Biggin, Spiridione Garbisa.   

Abstract

BACKGROUND: Some proteases involved in extracellular matrix degradation are instrumental not only in overcoming tissue barriers to allow normal extravasation of hematic cells, but also in facilitating pathological processes such as inflammation, angiogenesis and tumor invasion. The possibility of blocking these enzymes has led to the development of synthetic inhibitors, though clinical trials have been disappointing owing to considerable side effects. However, long before enzymes were first isolated, these same pathologies were being treated in plant-based folk remedies, and today science is screening them for their reputed beneficial effects. STATE OF THE ART: We present studies of 2 vegetable components as protease inhibitors. The first, (-)epigallocatechin-3-gallate - from green tea, has proved a good weapon for inhibiting gelatinases MMP-2 and MMP-9, but an even better inhibitor of leukocyte elastase (LE) activity; in vivo it blocks inflammation, angiogenesis and tumor invasion. The second, hyperforin - from Hypericum sp, inhibits LE-triggered activation of MMP-9, PMN chemotaxis and chemoinvasion, PMN-triggered angiogenesis, and inflammation-triggered pulmonary fibrosis; it also represses tumor-cell expression of MMP-2, thereby restraining invasion and metastasis.
CONCLUSION: Modern research clearly vindicates epidemiological and historical evidence of the beneficial effects of two long-used allies from the plant kingdom, going a step beyond by shedding light on mechanistic keys.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382921     DOI: 10.1016/j.cca.2007.02.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Labeled content of two furanocoumarins in dietary supplements correlates with neither actual content nor CYP3A inhibitory activity.

Authors:  Karen M VanderMolen; Garrett R Ainslie; Mary F Paine; Nicholas H Oberlies
Journal:  J Pharm Biomed Anal       Date:  2014-06-02       Impact factor: 3.935

2.  Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum.

Authors:  Wendy Maury; Jason P Price; Melinda A Brindley; ChoonSeok Oh; Jeffrey D Neighbors; David F Wiemer; Nickolas Wills; Susan Carpenter; Cathy Hauck; Patricia Murphy; Mark P Widrlechner; Kathleen Delate; Ganesh Kumar; George A Kraus; Ludmila Rizshsky; Basil Nikolau
Journal:  Virol J       Date:  2009-07-13       Impact factor: 4.099

3.  Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.

Authors:  Faten Merhi; Ruoping Tang; Marion Piedfer; Julie Mathieu; Isabelle Bombarda; Murhaf Zaher; Jean-Pierre Kolb; Christian Billard; Brigitte Bauvois
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

4.  Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

Authors:  Roy Moncayo
Journal:  EJNMMI Res       Date:  2011-07-26       Impact factor: 3.138

5.  Hydrophilic extract from Posidonia oceanica inhibits activity and expression of gelatinases and prevents HT1080 human fibrosarcoma cell line invasion.

Authors:  Emanuela Barletta; Matteo Ramazzotti; Florinda Fratianni; Daniela Pessani; Donatella Degl'Innocenti
Journal:  Cell Adh Migr       Date:  2015-07-15       Impact factor: 3.405

6.  Chemical Composition and New Biological Activities of Essential Oil and Hydrosol of Hypericum perforatum L. ssp. veronense (Schrank) H. Lindb.

Authors:  Elma Vuko; Valerija Dunkić; Mirko Ruščić; Marija Nazlić; Nela Mandić; Barbara Soldo; Matilda Šprung; Željana Fredotović
Journal:  Plants (Basel)       Date:  2021-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.